Examkin

Question

Difficulty: HardPreventive Care and Screening

A 32-year-old nulliparous woman arrives at the outpatient clinic to establish primary care. She reports excellent overall health and exercises regularly. She has no gastrointestinal complaints, unexplained weight changes, or evidence of bleeding. Her medical background is notable only for an appendectomy during childhood. Family history is significant for her mother, who was diagnosed with an early-stage colonic adenocarcinoma at the age of 46 and underwent a curative hemicolectomy. Medical records confirm the mother's tumor underwent mismatch repair protein analysis, demonstrating no loss of nuclear expression. Her maternal grandfather developed a similar intestinal malignancy at the age of 72. The patient expresses anxiety regarding her familial susceptibility and inquires about the optimal timing and modality for her own surveillance. Based on current evidence-based guidelines, which of the following is the most appropriate strategy for this patient?

  1. Initiate colonoscopic evaluation at age 36, with subsequent examinations every 5 yearsAnswer
  2. B
    Initiate colonoscopic evaluation at age 40, with subsequent examinations every 10 years
  3. C
    Initiate annual fecal immunochemical testing at age 36, with endoscopic follow-up if positive
  4. D
    Perform a baseline colonoscopic evaluation now due to the presence of malignancy in two successive generations
  5. E
    Defer any screening until age 45, at which time any approved structural or stool-based modality may be selected

Answer

Initiate colonoscopic evaluation at age 36, with subsequent examinations every 5 years
The patient is at increased risk for colorectal cancer due to a first-degree relative (her mother) diagnosed before age 60. According to the US Multi-Society Task Force on Colorectal Cancer, individuals with this family history must begin screening at age 40, OR 10 years earlier than the youngest age of diagnosis in the family, whichever comes first. Since the mother was diagnosed at age 46, this patient must begin screening at age 36 (10 years earlier), as it is sooner than age 40. For high-risk individuals, the only appropriate modality is direct structural visualization via colonoscopy, and the required surveillance interval is every 5 years if the initial exam is normal. Furthermore, the mother's intact mismatch repair proteins lower the clinical suspicion for Lynch syndrome, confirming that earlier empirical screening (e.g., immediately at age 32) is not indicated.

Step-by-Step Solution

1
Assess the patient's colorectal cancer risk level based on family history.
High risk due to a first-degree relative (mother) diagnosed at age < 60.
Family history dictates the starting age, screening modality, and surveillance frequency.
2
Determine the appropriate starting age for high-risk screening.
Start at age 36. The rule is age 40 OR 10 years prior to the relative's diagnosis, whichever is earlier. Mother's diagnosis at 46 minus 10 equals 36.
Applying the exact US Multi-Society Task Force guidelines for high-risk familial CRC ensures timely detection.
3
Determine the appropriate modality and surveillance interval.
Colonoscopy every 5 years.
High-risk patients require structural exams (colonoscopy); non-invasive stool tests are inadequate. The high-risk interval is 5 years.
4
Rule out the immediate need for hereditary cancer syndrome screening.
The mother's normal mismatch repair analysis makes Lynch syndrome unlikely, so screening does not need to start immediately at age 32.
Ensures premature invasive testing is avoided while adhering strictly to empirical family history algorithms.

Key Concept

Patients with a first-degree relative diagnosed with colorectal cancer before age 60 require screening colonoscopy starting at age 40 or 10 years before the relative's diagnosis (whichever is earlier), repeated every 5 years.
Rate this question

Topics

Preventive Care and Screening

More questions from this topic